Jessica L Geiger

5PUBLICATIONS

87CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 25, 2026

Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|May 31, 2026

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|May 05, 2026

Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9.

|Feb 11, 2026

Bridging the Gap: What We Can Learn From LEAP-010 in Recurrent/Metastatic Head and Neck Cancer.

Jenny Xiang, Jessica L Geiger

|Aug 08, 2024

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Justin F Gainor, Manish R Patel, Jeffrey S Weber

Pageof 1

Frequent Collaborators

Julie E Bauman

Ari J Rosenberg

Paul L Swiecicki

Justin F Gainor

Manish R Patel

Jeffrey S Weber

Martin Gutierrez

Jeffrey M Clarke

Robert L Ferris

Aaron J Scott

Frequent Collaborators

Julie E Bauman

Ari J Rosenberg

Paul L Swiecicki

Justin F Gainor